INFLAMMATORY RESPONSES IN THE TOXICITY OF RICIN
蓖麻毒素毒性的炎症反应
基本信息
- 批准号:7907295
- 负责人:
- 金额:$ 7.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbrinAcuteAdenineAdhesionsAffectAnimalsApicalApoptosisApoptosis PromoterApoptoticAppearanceAttentionBacteriaCaspase InhibitorCell DeathCell membraneCellsCessation of lifeClinicalCultured CellsDepurinationDevelopmentDiseaseE-SelectinEmploymentEndothelial CellsEscherichia coliEventExhibitsExperimental Animal ModelFamilyGene ActivationGene SilencingGenesGeneticGenetic EngineeringGenetic TranscriptionGerm CellsHealthHemolysisHemolytic-Uremic SyndromeHistocompatibility TestingHomologous ProteinHumanInfiltrationInflammationInflammatoryInflammatory ResponseInhibition of ApoptosisInterleukin-1IntoxicationKidneyKidney FailureKnock-outKnockout MiceLaboratoriesLeadLesionLeukocytesLigandsLungMAP Kinase GeneMAPK14 geneMAPK8 geneMeasuresMediatingMediator of activation proteinMessenger RNAMethodsMitochondriaModelingMolecularMusOligonucleotide MicroarraysOrganOrganismPassive ImmunizationPathologyPathway interactionsPhosphotransferasesPisum sativumPlantsPlayPoisoningPopulationPrecatory Bean PlantPredispositionPrimer ExtensionProtein InhibitionProtein Synthesis InhibitionRNA, Ribosomal, 28SRattusRecombinantsResistanceRibosomesRicinRiskRoleSeedsSerumShiga ToxinSignal TransductionStem cellsTarget PopulationsThrombocytopeniaTissuesToxic effectToxinTranscriptional ActivationTranslationsTumor Necrosis Factor ReceptorUrsidae FamilyVascular SystemViralcaspase-8caspase-9cell typechemokinecytochrome ccytokinecytotoxicextracellularimprovedin vivokidney celllaser capture microdissectionmacrophagemembermouse modelresponsestemstress activated protein kinasetranscription factor
项目摘要
DESCRIPTION (provided by applicant): In view of its wide availability and ease of purification, ricin has been employed as a toxic and lethal agent by totalitarian regimes and, recently, by terrorist groups. Ricin is a member of a family of ribosome-directed toxins whose toxicity stems from the depurination of a single adenine within the "sarcin/ricin" loop of 28S ribosomal RNA (28S rRNA). The depurination of 28S rRNA results not only in the inhibition of protein translation, but also the intense and extended activation of the stress-activated protein kinases such as JNK and p38 MAPK. These kinases are thought to be central mediators of inflammatory responses that are responsible for inducing the transcription of proinflammatory cytokines and chemokines. The development of interventional remedies in cases of poisoning by ricin and other ribosome-directed toxins will depend critically on our improved understanding of the primary target tissues affected and the mechanisms that drive the proinflammatory and cytotoxic responses. When administered to cultured cells or to mice, ricin potently induces the activation of genes that encode proinflammatory cytokines and chemokines and the transcription factors that are known to drive their expression. Simultaneously, ricin activates apoptotic pathways, via engagement of apical caspases 8 and 9, which lead to cell death. Our preliminary studies support the notion that the health risks that accompany ricin intoxication stem from ricin' s activation of inflammatory and apoptotic pathways. In this application we propose to employ ricin in both cultured cells and in wild-type and "knockout" mice to elucidate the initial targets of action, the cytotoxic consequences, and the cellular and molecular mechanisms that are pursuant to intoxication by ricin. In this application we propose to: 1) identify target tissues and cell types affected by ricin in a mouse model of ricin intoxication; 2) identify genes whose expression is induced by ricin in specific cell and tissue types; 3) determine the mechanisms of apoptosis triggered by ricin and the roles of apoptosis in the course of ricin-induced inflammation; and 4) elucidate the roles of specific inflammatory or pro-apoptotic genes in mediating the response to ricin intoxication by employing mouse "knock out" models.
描述(申请人提供):鉴于其广泛的可用性和易于纯化,蓖麻毒素已被极权主义政权用作有毒和致命的制剂,最近还被恐怖主义团体用作。蓖麻毒素是核糖体定向毒素家族的成员,其毒性源于28 S核糖体RNA(28 S rRNA)的“八叠球菌毒素/蓖麻毒素”环内的单个腺嘌呤的脱嘌呤。28 SrRNA的脱嘌呤不仅导致蛋白质翻译的抑制,而且还导致应激激活蛋白激酶如JNK和p38 MAPK的强烈和延长的激活。这些激酶被认为是负责诱导促炎细胞因子和趋化因子转录的炎症反应的中心介质。在蓖麻毒素和其他核糖体定向毒素中毒的情况下,干预治疗的发展将严重依赖于我们对受影响的主要靶组织和驱动促炎和细胞毒性反应的机制的更好理解。当给予培养的细胞或小鼠时,蓖麻毒素有效地诱导编码促炎细胞因子和趋化因子的基因以及已知驱动其表达的转录因子的激活。同时,蓖麻毒素激活凋亡途径,通过参与顶端半胱天冬酶8和9,导致细胞死亡。我们的初步研究支持这样的观点,即伴随蓖麻毒素中毒的健康风险源于蓖麻毒素激活炎症和凋亡途径。在本申请中,我们建议采用蓖麻毒素在培养的细胞和野生型和“敲除”小鼠阐明的初始目标的行动,细胞毒性的后果,以及细胞和分子机制,是根据中毒蓖麻毒素。在本申请中,我们提出:1)在蓖麻毒素中毒的小鼠模型中鉴定受蓖麻毒素影响的靶组织和细胞类型; 2)鉴定在特定细胞和组织类型中由蓖麻毒素诱导表达的基因; 3)确定由蓖麻毒素触发的细胞凋亡的机制以及细胞凋亡在蓖麻毒素诱导的炎症过程中的作用;和4)通过采用小鼠“敲除”模型阐明特定的炎症或促凋亡基因在介导蓖麻毒素中毒反应中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE E. MAGUN其他文献
BRUCE E. MAGUN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE E. MAGUN', 18)}}的其他基金
Targeting IL-1beta as a strategy for symptom control in cancer
以 IL-1beta 为靶点作为癌症症状控制策略
- 批准号:
8686620 - 财政年份:2012
- 资助金额:
$ 7.89万 - 项目类别:
Targeting IL-1beta as a strategy for symptom control in cancer
以 IL-1beta 为靶点作为癌症症状控制策略
- 批准号:
8372128 - 财政年份:2012
- 资助金额:
$ 7.89万 - 项目类别:
Targeting IL-1beta as a strategy for symptom control in cancer
以 IL-1beta 为靶点作为癌症症状控制策略
- 批准号:
8541060 - 财政年份:2012
- 资助金额:
$ 7.89万 - 项目类别:
Targeting IL-1beta as a strategy for symptom control in cancer
以 IL-1beta 为靶点作为癌症症状控制策略
- 批准号:
8876408 - 财政年份:2012
- 资助金额:
$ 7.89万 - 项目类别:
INFLAMMATION AND APOPTOSIS IN EXPERIMENTAL HEMOLYTIC UREMIC SYNDROME
实验性溶血性尿毒综合征中的炎症和细胞凋亡
- 批准号:
7173439 - 财政年份:2005
- 资助金额:
$ 7.89万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 7.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 7.89万 - 项目类别:
Operating Grants














{{item.name}}会员




